Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
Ocular Therapeutix’s glaucoma treatment fails to meet primary endpoint in P3 trial, for gets statistically significant reduction of intraocular pressure versus placebo
May 20, 2019 Off

Ocular Therapeutix’s glaucoma treatment fails to meet primary endpoint in P3 trial, for gets statistically significant reduction of intraocular pressure versus placebo

By BusinessWire

OTX-TP failed to meet primary endpoint but achieved statisticallysignificant reduction of intraocular pressure versus placebo at eight ofthe nine pre-specified time points

Clovis Oncology’s Rubraca Rubraca passes over placebo from a patient perspective in Advanced Ovarian Cancer
May 20, 2019 Off

Clovis Oncology’s Rubraca Rubraca passes over placebo from a patient perspective in Advanced Ovarian Cancer

By BusinessWire

Quality-adjusted progression free survival (QA-PFS) andquality-adjusted time without cancer related symptoms or toxicity(Q-TWiST) demonstrate the benefit of Rubraca maintenance treatment overplacebo from a patient perspective

Verona Pharma finds more symptoms benefits from ensifentrine  in COPD patients
May 20, 2019 Off

Verona Pharma finds more symptoms benefits from ensifentrine in COPD patients

By Dino Mustafić

Verona Pharma posted Monday expanded analysis to positive results from March, from from findings from its chronic obstructive pulmonary disease (“COPD”) clinical trial program with lead product candidate, ensifentrine (RPL554). Positive results from the 4-week, 400-patient Phase 2b study were initially reported in March 2018.

May 20, 2019 Off

Frelii Files Quarterly Report on Form 10-Q

By BusinessWire

LEHI, Utah–(BUSINESS WIRE)–Frelii Inc. (OTCQB: FRLI) (“Frelii” or “the Company”) today announced that on May 20, 2019, it filed with…

May 20, 2019 Off

Former U.S. Secretary of Agriculture and Iowa Governor to Receive 2019 George Washington Carver Award

By BusinessWire

WASHINGTON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/BIOWC19?src=hash" target="_blank"gt;#BIOWC19lt;/agt;–The Biotechnology Innovation Organization (BIO) today announced that former U.S. Department of Agriculture (USDA) Secretary and former…

May 20, 2019 Off

Second-Generation Blood Test for Irritable Bowel Syndrome (IBS) Validated as Providing Most Conclusive Diagnosis of Inclusion for IBS

By BusinessWire

SAN DIEGO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/guthealth?src=hash" target="_blank"gt;#guthealthlt;/agt;–Gemelli Biotech, in partnership with the Medically Associated Science and Technology (MAST) program at Cedars-Sinai, announced…

U.S. District Court rules Dana-Farber scientist Gordon Freeman, PhD,was co-inventor of all six patents in issue
May 20, 2019 Off

U.S. District Court rules Dana-Farber scientist Gordon Freeman, PhD,was co-inventor of all six patents in issue

By BusinessWire

U.S. District Court rules Dana-Farber scientist Gordon Freeman, PhD,was co-inventor of all six patents in issue

Ayala Pharmaceuticals’ preclinical data supports clinical development of AL101 in TripleNegative Breast Cancer (TNBC) tumors bearing Notch mutation
May 20, 2019 Off

Ayala Pharmaceuticals’ preclinical data supports clinical development of AL101 in TripleNegative Breast Cancer (TNBC) tumors bearing Notch mutation

By BusinessWire

– Ongoing Phase 2 ACCURACY study to explore AL101 and its effect on tumor growth inhibition in people with Adenoid…

Global pulmonary embolism therapeutics market to post 9% CAGR over next five years
May 20, 2019 Off

Global pulmonary embolism therapeutics market to post 9% CAGR over next five years

By BusinessWire

The global pulmonary embolism therapeutics market is expected to post aCAGR of more than 9% during the period 2019-2023, according to thelatest market research report by Technavio.

May 20, 2019 Off

Categorical Response and Clinical Relevance as Assessed in a Phase III Study of HP-3070 (Asenapine) Transdermal Patch for the Treatment of Schizophrenia to be Presented at the American Psychiatric Association 172nd Annual Meeting

By BusinessWire

New Drug Application for HP-3070 under FDA review MIAMI & JERSEY CITY, N.J.–(BUSINESS WIRE)–Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of…

Posts pagination

Previous 1 … 3,177 3,178 3,179 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine